| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/10/2004 | US20040110243 luminescence output (HALO) kit comprising a vessel or vessels containing a serum mix, a methyl cellulose mix, a growth factor mix, a medium, an ATP-releasing reagent, and an ATP luminescence-monitoring reagent |
| 06/10/2004 | US20040110242 reacts with prothrombin forming a complex with phosphatidylserine (PS/PT) but does not react with prothrombin (PT) not forming a complex with phosphatidylserine |
| 06/10/2004 | US20040110241 Materials and methods for monitoring vascular endothelial function |
| 06/10/2004 | US20040110239 Detection to the HER2 receptor by means of biotinilated humanized antibody |
| 06/10/2004 | US20040110238 Constitutively activated human G protein coupled receptors |
| 06/10/2004 | US20040110237 Protein localization assays for toxicity and antidotes thereto |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110234 Method of detecting colon cancer |
| 06/10/2004 | US20040110233 Methods for screening compound libraries |
| 06/10/2004 | US20040110231 Screening method |
| 06/10/2004 | US20040110230 Method for determining concentrations of analytes |
| 06/10/2004 | US20040110229 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence |
| 06/10/2004 | US20040110228 Combinatorial organic synthesis of unique biologically active compounds |
| 06/10/2004 | US20040110227 for systematically identifying novel chromosomal rearrangements, RNA transcript chimerism for diagnosing and/or treating a variety of disorders associated with genetic rearrangements |
| 06/10/2004 | US20040110224 Segment synthesis |
| 06/10/2004 | US20040110223 Method for detecting an analyte by fluorescence |
| 06/10/2004 | US20040110222 Biopolymer detecting method and biochip |
| 06/10/2004 | US20040110221 Methods for diagnosing RCC and other solid tumors |
| 06/10/2004 | US20040110220 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 06/10/2004 | US20040110219 Detecting amount of nucleic acid encoding UKW polypeptide through hybridization and comparing with a predetermined standard value |
| 06/10/2004 | US20040110212 Microarrays with visual alignment marks |
| 06/10/2004 | US20040110205 Introducing polynucleotides and polypeptides into a device which includes a structure having an aperture therethrough; forming and analyzing the distribution pattern from the information obtained |
| 06/10/2004 | US20040110199 Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| 06/10/2004 | US20040110198 Detecting the level of reagent that selectively associates with a polynucleotide or polypeptide encoded by a nucleic acid that hybridizes to given sequence; calcium/calmodulin dependent protein kinase (CAMKII- alpha ) and TBR1; use in diagnosis |
| 06/10/2004 | US20040110196 to extend the life and slow the rate of oxidation of signal generating dyes and labels including fluorescent molecules used in association with assay substrates; coating is an ethyl methacrylate-methyl methacrylate copolymer transparent to signal |
| 06/10/2004 | US20040110186 Methods for isolating and labeling sample molecules |
| 06/10/2004 | US20040110183 Methods for the survey and genetic analysis of populations |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110178 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use |
| 06/10/2004 | US20040110177 Method for identifying functional nucleic acids |
| 06/10/2004 | US20040110173 Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene |
| 06/10/2004 | US20040110171 Identifying transcriptional regulators which control axonal guidance for use as treatments of age related neurodegenerative diseases |
| 06/10/2004 | US20040110168 Diagnostics and therapeutics for osteoporosis |
| 06/10/2004 | US20040110167 Rapid and accurate detection of amplified and nonamplified nucleic acid sequences while being simple, economical and ready to use; self-contained; device contains all reagents necessary for the assay in an anhydrous format |
| 06/10/2004 | US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics |
| 06/10/2004 | US20040110154 Method for creating specific, high affinity nuclear receptor pharmaceuticals |
| 06/10/2004 | US20040110137 Using fluorescent-light intensity waveform data to determine sequence of target nucleic acids; identifying restriction fragment length polymorphisms |
| 06/10/2004 | US20040110136 Using solid support comprising coded and labeled microspheres/beads for detecting unknown biological targets |
| 06/10/2004 | US20040110128 Comprises tagged nanoparticles associated with specific integrated circuits and ligated to oligonucleotide for use as diagnostic tools in DNA sequencing |
| 06/10/2004 | US20040110126 Hcv polymerase inhibitor assay |
| 06/10/2004 | US20040110124 Method of enhancing radiation resistance of normal cells |
| 06/10/2004 | US20040110123 Ion channel assay methods |
| 06/10/2004 | US20040110122 Using mixture comprising labeled monoclonal antibodies, 7-aminoactinomycin, fluorescein isothiocyanate, and phycoerythrin to accurately monitor and immunophenotype peripheral blood |
| 06/10/2004 | US20040110002 Semiconductor nanocrystal heterostructures |
| 06/10/2004 | US20040109884 Polymers containing silane groups |
| 06/10/2004 | US20040109868 Pim kinase-related methods |
| 06/10/2004 | US20040109863 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109862 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109860 Using immunoglobulins that blocks nerve growth factor; therapy for central nervous system disorders |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109850 Treatment of bone disorders by modulation of fgfr3 |
| 06/10/2004 | US20040109790 transparent over the measurement area; area can be illuminated by a light source on one side and the transmitted light measured on the opposite side; measuring prothrombin time from whole blood |
| 06/10/2004 | US20040108859 Method for measuring high requency resistance in Diesel engine lubrication oil |
| 06/10/2004 | US20040108630 Electromagnetic method and apparatus for treatment of engineering materials, porducts, and related processes |
| 06/10/2004 | US20040108472 Method and system for detecting chemical substance |
| 06/10/2004 | US20040108452 Method for characterizing biomolecules utilizing a result driven strategy |
| 06/10/2004 | US20040108226 Continuous glucose quantification device and method |
| 06/10/2004 | US20040108225 Data processing controller; syringe and electrochemical immunoassay biosensor; voltage supplier for applying potential difference |
| 06/10/2004 | US20040108214 Methods for determination of additive concentration in metal plating baths |
| 06/10/2004 | US20040108197 Solid-state light source photolytic nitrogen dioxide converter |
| 06/10/2004 | US20040107912 Methods and apparatus for identifying live eggs by detecting embryo heart rate and/or motion |
| 06/10/2004 | US20040107766 Health monitor |
| 06/10/2004 | US20040107763 Method and apparatus for monitoring oxygen concentration in a beverage production process |
| 06/10/2004 | CA2721200A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | CA2704070A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | CA2691447A1 Ca ix-specific inhibitors |
| 06/10/2004 | CA2547331A1 Electro-optical nucleic acid-based sensor array and method for detecting analytes |
| 06/10/2004 | CA2507725A1 Method of measuring lipid in specific lipoprotein |
| 06/10/2004 | CA2507565A1 System and method for tracking environmental emission reductions |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507113A1 System and method of creating, aggregating, and transferring environmental emission reductions |
| 06/10/2004 | CA2507112A1 Controls and standards for assays and method for manufacture thereof |
| 06/10/2004 | CA2507044A1 Purinergic modulation of smell |
| 06/10/2004 | CA2507018A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 06/10/2004 | CA2506959A1 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 06/10/2004 | CA2506738A1 Composition for treating chlamydia infections and method for identifying same |
| 06/10/2004 | CA2506686A1 Cct6s as modifiers of the rb pathway and methods of use |
| 06/10/2004 | CA2506683A1 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | CA2506666A1 Nact as a target for lifespan expansion and weight reduction |
| 06/10/2004 | CA2506607A1 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 06/10/2004 | CA2506513A1 Sol-gel biosensors |
| 06/10/2004 | CA2506356A1 Methods of therapy and diagnosis |
| 06/10/2004 | CA2506260A1 Method of immobilizing biomolecule to metallic carrier |
| 06/10/2004 | CA2506259A1 Method and apparatus for detecting mastitis |
| 06/10/2004 | CA2506197A1 Detection of protease enzymes |
| 06/10/2004 | CA2506037A1 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | CA2505589A1 Probe for determination of oxygen activity in metal melts and methods for its production |
| 06/10/2004 | CA2505416A1 Methods for diagnosing rcc and other solid tumors |
| 06/10/2004 | CA2504856A1 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 06/10/2004 | CA2504498A1 Molecular nephrotoxicology modeling |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2503736A1 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 06/10/2004 | CA2503292A1 Constellation mapping and uses thereof |
| 06/10/2004 | CA2503246A1 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | CA2485950A1 Methods for cohort selection and longevity studies |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/09/2004 | EP1426768A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |